Research Article

Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism of Yiqi Yangyin Decoction in Suppressing Non-Small-Cell Lung Cancer

Table 1

Active compounds of YYD.

MarkCompound nameMOL IDOB (%)DLHLHerb

A1StigmasterolMOL00044943.830.765.57PG/OJ/LB
A2Beta-sitosterolMOL00035836.910.755.36PG/PR/LB/AAR
A3KaempferolMOL00042241.880.2414.74PG/AE
PG1ChrysanthemaxanthinMOL00449238.720.5817.47PG
PG2CelabenzineMOL005314101.880.498.15PG
PG3DeoxyharringtonineMOL00531739.270.817.9PG
PG4DianthramineMOL00531840.450.25.14PG
PG5ArachidonateMOL00532045.570.27.56PG
PG6Frutinone AMOL00532165.90.3419.1PG
PG7Ginsenoside rh2MOL00534436.320.5611.08PG
PG8Ginsenoside-Rh4_qtMOL00534831.110.786.97PG
PG9GirinimbinMOL00535661.220.318.17PG
PG10Gomisin BMOL00535731.990.837.81PG
PG11MalkanguninMOL00536057.710.634.09PG
PG12PanaxadiolMOL00537633.090.796.34PG
PG13SuchilactoneMOL00538457.520.569.03PG
PG14Alexandrin_qtMOL00539936.910.755.53PG
PG15Ginsenoside Rg5_qtMOL00540139.560.795.65PG
PG16FumarineMOL00078759.260.8323.46PG
PG17InerminMOL00364865.830.5411.73PG
AE1LuteolinMOL00000636.160.2515.94AE
AE2QuercetinMOL00009846.430.2814.4AE
TR1SpinasterolMOL00435542.980.765.32TR
TR2SchottenolMOL00675637.420.755.63TR
PR1SitosterolMOL00035936.910.755.37PR
PR2Methylprotodioscin_qtMOL00388935.120.865.48PR
PR3(2R)-7-Hydroxy-2-(4-hydroxyphenyl)chroman-4-oneMOL00494171.120.1818.09PR
PR4DiosgeninMOL00054680.880.814.14PR
PR54,5-DihydroxyflavoneMOL00633148.550.1918.01PR
PR6Sibiricoside A_qtMOL00976035.260.865.44PR
PR7Zhonghualiaoine 1MOL00976634.720.785.25PR
PR8LiquiritigeninMOL00179232.760.1817.89PR
PR9BaicaleinMOL00271433.520.2116.25PR
PR103-MethoxydaidzeinMOL00295948.570.2417.04PR
LB126-Dihydroxy-choleslen-16MOL00944932.430.86.02LB
LB226-Dihydroxy-5-cholesten-16MOL00946535.110.814.15LB
LB326-Dihydroxy-cholestan-16MOL00947132.430.85.73LB
AAR1MandenolMOL001494420.195.39AAR
AAR2Ethyl oleate (NF)MOL00288332.40.194.85AAR
AAR3Cycloartenol acetateMOL00347941.110.86.9AAR